MedLife, the largest network of private medical services in Romania, is organizing these days (May 14-16), the first edition of UROLink – the National Conference of Advanced Techniques in Uro-Oncology, a medical event dedicated to innovation, robotic surgery and precision oncology in urology. The conference brings together specialists from Romania and abroad, in a multidisciplinary format focused on the exchange of experience and the integration of the latest technologies in medical practice.
Organized in Sibiu, the UROLink conference brings together urologists, oncologists, radiologists and specialists from related fields, in scientific sessions dedicated to the latest therapeutic and technological approaches in uro-oncology. Central themes include robotic surgery, laser technologies, precision oncology and modern management of complex urological pathologies.
“UROLink reconfirmed the importance of continuous investment in medical education, technology and collaboration between specialties. For MedLife, the development of such professional platforms is part of our commitment to bring the medicine of the future closer to patients, through access to expertise, innovation and modern standards of treatment”, said Nicolae Marcu, Director of Health and Operations of MedLife.
The scientific program includes presentations by renowned lecturers from Romania and abroad, alongside numerous specialists actively involved in the development of minimally invasive and robotic surgery in Romania. The conference emphasizes the practical applicability of new technologies and their integration in the treatment of oncological patients, in a context where precision medicine and robotic-assisted surgery are increasingly transforming therapeutic standards in urology.
At the same time, the event also included an important practical component, through live transmissions from the operating room of some complex surgical interventions, giving participants the opportunity to watch in real time modern robotic surgery techniques and minimally invasive approaches used in the treatment of uro-oncological pathologies.
“Through UROLink we want to create a real space for the exchange of experience between specialists, with an emphasis on the practical applicability of advanced technologies in uro-oncology. Robotic surgery and minimally invasive approaches significantly change the way we treat the urological patient, offering precision, safety and better chances of recovery”, said Dr. Valentin Pîrvuț, urology primary physician.
The conference also includes a medical exhibition dedicated to the latest equipment and technologies used in urology and robotic surgery, offering participating doctors direct access to innovative solutions and current trends in the field.
Through the organization of UROLink, MedLife continues to support the development of medical education and the integration of advanced technologies in clinical practice, at the same time strengthening the role of MedLife Hospital Polisano Sibiu as a reference center in robotic surgery and multidisciplinary management of uro-oncological pathologies.
About the MedLife Group
MedLife started almost three decades ago, developed healthily and became the largest provider of private medical services in Romania. The Romanian entrepreneurs, who laid the foundations of this company, invested and got involved to bring change in the Romanian health system, believed in innovation and dared to aim as high as possible, to offer Romanian patients quality, professionalism, care and respect for their needs.
The company operates the most extensive network of clinics, one of the largest networks of medical laboratories, general and specialized hospitals and has the largest corporate client base for Health Prevention Packages in the country. It is also, in terms of sales, one of the largest private healthcare players in Central and Eastern Europe.
The MedLife Group has a successful track record of both organic and acquisition growth. Its strong and experienced management team has been able to create and manage these growth opportunities, gaining valuable knowledge and experience to enable it to find the best path for continued successful expansion.
Being a Romanian company with tradition, MedLife chose to list on the Romanian Stock Exchange, being a model of listings on the local capital market. It opened horizons, and through the corporate governance it has implemented, it inspired other local companies to start on this path and help the development of Romanian capital and the economy. The shares issued by MedLife SA are admitted to trading on the regulated spot market administered by the Bucharest Stock Exchange, Premium Category, with the trading symbol ″M″.
During the pandemic, MedLife managed to play an essential role in society and gain a leadership status in monitoring the pandemic through active involvement in the research area.
The company continues to invest in projects with an impact on the local community, in technology and infrastructure. It creates jobs and develops an ecosystem that contributes to the development and maintenance of a healthy Romania.
